StockData

Endovia Health Sciences, Inc. (EDVA) stock

EDVANYSEBeveragesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 0/30
$0.17−0.00 (-1.46%)

Close on Nov 17, 2026Market cap $126.28KP/E –Yield –

Endovia Health Sciences revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Endovia Health Sciences's revenue for the twelve months ending Sep 30, 2025 was $1.42M, down 77.4% year over year. For fiscal 2025 it was $73.07K, down 90.9% from the year before. Over ten years it grew -22.2% a year on average. The highest annual figure on record is $18.85M in fiscal 2023.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$73.07K-90.9%
FY2024Dec 31, 2024$801.27K-95.7%
FY2023Dec 31, 2023$18.85M+4.2%
FY2022Dec 31, 2022$18.09M+59.8%
FY2021Dec 31, 2021$11.32M+392.0%
FY2020Dec 31, 2020$2.30M+11182.3%
FY2019Dec 31, 2019$20.39K-98.4%
FY2018Dec 31, 2018$1.31M+46.2%
FY2017Dec 31, 2017$895.35K-11.6%
FY2016Dec 31, 2016$1.01M+12.8%
FY2015Dec 31, 2015$897.34K+48.1%
FY2014Dec 31, 2014$605.91K+27.5%
FY2013Dec 31, 2013$475.25K+53.9%
FY2012Dec 31, 2012$308.73K+8.8%
FY2011Dec 31, 2011$283.83K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$0-100.0%
Q1 FY2026Mar 31, 2026$4.22K-99.3%
Q3 FY2025Sep 30, 2025$393.07K-60.0%
Q2 FY2025Jun 30, 2025$369.67K-64.7%
Q1 FY2025Mar 31, 2025$68.61K-95.5%
Q4 FY2024Dec 31, 2024$585.89K-78.2%
Q3 FY2024Sep 30, 2024$981.86K-80.9%
Q2 FY2024Jun 30, 2024$1.05M-78.2%
Q1 FY2024Mar 31, 2024$1.54M-68.4%
Q4 FY2023Dec 31, 2023$2.69M-40.2%
Q3 FY2023Sep 30, 2023$5.14M+31.0%
Q4 FY2022Dec 31, 2022$4.79M+56.5%
Q3 FY2022Sep 30, 2022$4.87M+72.3%
Q2 FY2022Jun 30, 2022$4.50M+36.8%
Q1 FY2022Mar 31, 2022$3.93M+83.6%
Q4 FY2021Dec 31, 2021$3.06M+182.9%
Q3 FY2021Sep 30, 2021$2.83M+308.0%
Q2 FY2021Jun 30, 2021$3.29M+696.6%
Q1 FY2021Mar 31, 2021$2.14M+1809.7%
Q4 FY2020Dec 31, 2020$1.08M+11.5%
Q3 FY2020Sep 30, 2020$692.97K+127.1%
Q2 FY2020Jun 30, 2020$412.73K+864.9%
Q1 FY2020Mar 31, 2020$112.00K+4102.7%
Q4 FY2019Dec 31, 2019$970.75K+227.1%
Q3 FY2019Sep 30, 2019$305.20K-2.5%
Q2 FY2019Jun 30, 2019$42.78K-87.9%
Q1 FY2019Mar 31, 2019$2.67K-99.2%
Q4 FY2018Dec 31, 2018$296.80K+90.6%
Q3 FY2018Sep 30, 2018$312.99K-1.9%
Q2 FY2018Jun 30, 2018$354.77K+68.5%
Q1 FY2018Mar 31, 2018$344.62K+64.1%
Q4 FY2017Dec 31, 2017$155.70K-50.8%
Q3 FY2017Sep 30, 2017$319.02K+35.1%
Q2 FY2017Jun 30, 2017$210.57K-10.8%
Q1 FY2017Mar 31, 2017$210.06K–
Q4 FY2016Dec 31, 2016$316.59K–
Q3 FY2016Sep 30, 2016$236.06K–
Q2 FY2016Jun 30, 2016$236.06K–

More Endovia Health Sciences figures

See a number that looks wrong?